Table 3.
Full blood count and biochemical characteristics of the groups.
| Group 1 (AHI < 5) |
Group 2 (AHI 5–15) |
Group 3 (AHI 15–30) |
Group 4 (AHI > 30) |
P value | |
|---|---|---|---|---|---|
| Patient number | 30 | 38 | 41 | 91 | |
|
| |||||
| WBC (×103 cell/µl) | 7.08 ± 1.37 | 7.27 ± 1.97 | 7.83 ± 1.79 | 7.89 ± 1.99 | 0.069 |
| RBC (×106 cell/µl) | 5.06 ± 0.58 | 5.23 ± 0.47 | 5.25 ± 0.48 | 5.19 ± 0.67 | 0.654 |
| Hb (g/dl) | 14.55 ± 1.42 | 14.97 ± 1.42 | 15.24 ± 1.40 | 15.08 ± 1.47 | 0.328 |
| Htc (%) | 43.76 ± 4.24 | 44.93 ± 3.89 | 44.29 ± 7.27 | 44.91 ± 5.87 | 0.808 |
| PLT (×103 cell/µl) | 271.57 ± 51.83 | 260.76 ± 64.52 | 266.76 ± 62.11 | 278.59 ± 84.64 | 0.597 |
| MPV (fl) | 9.21 ± 0.75 | 9.36 ± 0.94 | 9.33 ± 0.72 | 9.37 ± 1.02 | 0.910 |
| PDW (fl) | 15.71 ± 2.12 | 16.19 ± 2.34 | 15.67 ± 1.91 | 15.84 ± 2.88 | 0.810 |
| Glucose (mg/dl) | 94.34 ± 9.58 | 95.70 ± 11.35 | 100.91 ± 10.69 | 99.31 ± 14.30 | 0.079 |
| Creatinine (mg/dl) | 0.70 ± 0.15 | 0.81 ± 0.14 | 0.8 (0.19) | 0.8 (0.2) | 0.684 |
| Total cholesterol (mg/dl) | 201.92 ± 47.72 | 201.88 ± 42.05 | 210.01 ± 43.06 | 207.43 ± 40.21 | 0.758 |
| HDL cholesterol (mg/dl) | 54.03 ± 12.79 | 42.5 (11.5) | 45.25 ± 12.72 | 40.48 ± 8.72 | 0.001∗ |
| LDL cholesterol (mg/dl) | 119.91 ± 41.91 | 119.62 ± 43.47 | 125.20 ± 41.56 | 127.49 ± 37.26 | 0.691 |
| Triglyceride (mg/dl) | 92.5 (83.83) | 128.45 (113) | 155.5 (155.6) | 196.45 (113.7) | 0.017∗ |
WBC: white blood cells; RBC: red blood cells; MPV: mean platelet volume; PDW: platelet distribution width; HDL: high-density lipoprotein cholesterol; LDL: low-density lipoprotein cholesterol; VLDL: very low density lipoprotein cholesterol; *P < 0.05.
Both HDL and triglyceride were found to be significantly high in severe OSAS group compared to normal population (P: 0.001 and P: 0.013).